Partnering
We build partnerships to bring meaningful change to patients.
Why Partner With Us
At Kardigan we are focused on bringing new, targeted cardiovascular medicines to people who need them most, and we pursue partnerships that enhance our ability to deliver impact. Our highly experienced management team has deep roots in research and development, with top tier translational and clinical science experience.
We have a proven track record of success in advancing a robust pipeline of cardiovascular medicines leveraging our Cardiac Intelligence platform to break the current cycle of drug discovery and development with a modernized approach.
We pride ourselves on being true collaborators. We are agile and highly skilled at understanding the unique needs of both large and small companies, as well as academic institutions.
Who Should Partner With Us
- Academic institutions and researchers looking for support in moving new science to or through clinical stage development
- Biotech companies looking to advance or reposition their technologies or products with us
- Established biopharma looking for collaboration opportunities in the cardiovascular disease space, including partnerships to expand global reach
Kardigan is open to a variety of structures (collaborations, licensing, asset acquisitions, etc.) to achieve mutual partnering goals.
A Shared Vision to Transform Cardiovascular Care
We welcome conversations with those who are working to discover, develop, and deliver new therapies. Some examples include, but are not limited to, partnerships that:
- Address disease areas that have substantial unmet medical need
- Target the root causes of cardiovascular disease
- Modify disease pathways in ways that reverse or mediate disease progression in clinically meaningful ways (vs. symptom management)
- Help people improve feel and function
Get In Touch With Us
To explore potential partnership opportunities, please reach out to us at [email protected].